Taysha Gene Therapies, Inc. TSHA PP&E (Net)
PP&E (Net) at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s PP&E (net)?
- Taysha Gene Therapies, Inc. (TSHA) reported PP&E (net) of $6.45M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s PP&E (net) changed year-over-year?
- Taysha Gene Therapies, Inc.'s PP&E (net) decreased by 10.9% year-over-year, from $7.24M to $6.45M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Taysha Gene Therapies, Inc.'s PP&E (net) has grown at a 88.0% compound annual growth rate (CAGR), from $287K to $6.74M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.